Artesunate and sulfadoxine-pyrimethamine combinations for the treatment of uncomplicated Plasmodium falciparum malaria in Uganda: A randomized, double-blind, placebo-controlled trial

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 97, Issue 3, 2003, Pages 325-330

  Priotto, Gerardo ^a   Kabakyenga, Jerome ^b   Pinoges, Loretxu ^a   Ruiz, Ana ^c   Eriksson, Therese ^c   Coussement, François ^c   Ngambe, Tharcise ^b   Taylor, Walter R J ^d   Perea, William ^a   Guthmann, Jean Paul ^a   Olliaro, Piero ^d   Legros, Dominique ^a  

^a EPICENTRE   (France)

^b MBARARA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Uganda)

^c MÉDECINS SANS FRONTIÈRES   (Switzerland)

^d WORLD BANK   (United States)

Author keywords

Artesunate; Chemotherapy; Malaria; Plasmodium falciparum; Sulfadoxine Pyrimethamine; Uganda

Indexed keywords

ARTESUNATE; CHLOROQUINE; FANSIDAR; MEFLOQUINE; PLACEBO; PROGUANIL; PYRIMETHAMINE; QUININE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG RESPONSE; DRUG URINE LEVEL; FEMALE; FOLLOW UP; HUMAN; HYPERBILIRUBINEMIA; INFANT; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALARIA; MALE; MASS SCREENING; METABOLIC DISORDER; OUTCOMES RESEARCH; PLASMODIUM FALCIPARUM; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TREATMENT FAILURE; TREATMENT OUTCOME; UGANDA; URINALYSIS;

ANTIMALARIALS; ARTEMISININS; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; MALARIA, FALCIPARUM; MALE; PARASITEMIA; PYRIMETHAMINE; SESQUITERPENES; SULFADOXINE; TREATMENT OUTCOME;

PLASMODIUM FALCIPARUM;

EID: 4444315205     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-9203(03)90161-1     Document Type: Article

References (36)

1. Adjuik M. Agnamey P. Babiker A. Borrmann S. Brasseur P. Cisse M. Cobelens F. Diallo S. Faucher J.F. Garner P. Gikunda S. Kremsner P.G. Krishna S. Lell B. Loolpapit M. Matsiegui P.B. Missinou M.A. Mwanza J. Ntoumi F. Olliaro P. Osimbo P. Rezbach P. Some E. Taylor W.R.J. Amodiaquineartesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: a randomized, multicentre trial Lancet 359 2002 1365-1372
2. Bayoumi R.A. Babiker H.A. Ibrahim S.M. Ghalib H.W. Saeed B.O. Khider S. Elwasila M. Karim E.A. Chloroquine-resistant Plasmodium falciparum in Eastern Sudan Acta Tropica 46 1989 157-165
3. Brandling-Bennett A.D. Oloo A.J. Watkins W.M. Boriga D.A. Kariuki D.M. Collins W.E. Chloroquine treatment of falciparum malaria in an area of Kenya of intermediate chloroquine resistance Transactions of the Royal Society of Tropical Medicine and Hygiene 82 1988 833-837
4. Brockman A. Paul R.E.L. Anderson T.J.C. Hackford L. Phaiphun L. Looareesuwan S. Nosten F. Day K.P. Application of genetic markers to the identification of recrudescent Plasmodium falciparum infections on the northwestern border of Thailand American ournal of Tropical Medicine and Hygiene 60 1999 14-21
5. Fowler V. Lemnge M. Irare S. Malecela E. Mhina J. Mtui S. Mashaka M. Mtoi R. Efficacy of chloroquine on lasmodium falciparum transmitted in Amani, eastern Usambara Mountains, northeast Tanzania: an area where malaria has recently become endemic Journal of Tropical Medicine and Hygiene 49 1993 337-345
6. Gorissen E. Ashruf G. Lamboo M. Bennebroek J. Gikunda S. Mbaruku G. Kager P.A. In vivo efficacy study of amodiaquine and sulfadoxine/pyrimethamine in Kibwezi, Kenya and Kigoma, Tanzania Tropical Medicine and International Health 5 2000 459-463
7. Irion A. Felger I. Abdulla S. Smith T. Mull R. Tanner M. Hatz C. Beck H.-P. Distinction of recrudescences from new infections by PCR-RFLP analysis in a comparative trial of CGP 56 697 and chloroquine in Tanzanian children Tropical Medicine and International Health 3 1998 490-497
8. Kamya M.R. Dorsey G. Gasasira A. Ndeezi G. Babirye J.N. Staedke S.G. Rosenthal P.J. The comparative efficacy of chloroquine and sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in Kampala, Uganda Transactions of the Royal Society of Tropical Medicine and Hygiene 95 2001 50-55
9. Lefèvre G. Looareesuwan S. Treeprasertsuk S. Krudsood S. Silachamroon U. Gathmann I. Mull R. Bakshi R. A clinical and pharmacokinetic trial of six doses of artemether-lumefantrine for multidrug-resistant Plasmodium falciparum malaria in Thailand American Journal of Tropical Medicine and Hygiene 64 2001 247-256
10. Legros D. Johnson K. Houpikian P. Makanga M. Kabakyenga J.K. Talisuna A.O. Taylor W.R.J. Clinical efficacy of chloroquine or sulfadoxinepyrimethamine in children under five from south western Uganda with uncomplicated falciparum malaria Transactions of the Royal Society of Tropical Medicine and Hygiene 96 2002 199-201
11. Lellouch J. Lazar P. Méthodes Statistiques en Expérimentation Biologique 1974 137-138 Médecine-Sciences FlammarionParis
12. Mount D. Nahlen B. Patchen L. Churchill F. Adaptations of the Saker-Salomons test: simple, reliable calorimetric field assays for chloroquine and its metabolites in urine Bulletin of the World Health Organization 67 1989 295-300
13. Mutabingwa T. Nzila A. Mberu E. Nduati E. Winstanley P. Hills E. Watkins W. Chlorproguanildapsone for treatment of drug-resistant falciparum malaria in Tanzania Lancet 358 2001 1218-1223
14. Nosten F. van Vugt M. Price R. Luxemburger C. Thway K.L. Brockman A. McGready R. ter Kuile F. Looareesuwan S. White N.J. Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study Lancet 356 2000 297-302
15. Nzila A.M. Mberu E.K. Sulo J. Dayo H. Winstanley P.A. Sibley C.H. Watkins W.M. Towards an understanding of the mechanism of pyrimethamine/sulfadoxine resistance in Plasmodium falciparum: genotyping of dihydrofolate reductase and dihydropteroate synthetase of Kenyan parasites Antimicrobial Agents and Chemotherapy 44 2000 991-996 996
16. Premji Z. Minjas J.N. Shiff C.J. Chloroquine resistant Plasmodium falciparum in coastal Tanzania. A challenge to the continued strategy of village based chemotherapy for malaria control Tropical Medicine and Parasitology 45 1993 47-48
17. Price R.N. Nosten F. Luxemburger C. ter Kuile F.O. Paiphun L. Chongsuphajaisiddhi T. White N.J. Effects of artemisinin derivatives on malaria transmissibility Lancet 347 1996-1654 1658
18. Rønn A.M. Msangeni H.A. Mhina J. Wernsdorfer W.H. Bygbjerg I.C. High level of resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine in children in Tanzania Transactions of the Royal Society of Tropical Medicine and Hygiene 90 1996 179-181 181
19. Sexton J.D. Deloron P. Bugilimfura L. Ntilivamunda A. Neill M. Parasitologic and clinical efficacy of 25 and 50 mg/kg of chloroquine for treatment of Plasmodium falciparum malaria in Rwandan children American Journal of Tropical Medicine and Hygiene 38 1988 237-243
20. Snounou G. Beck H.P. The use of PCR genotyping in the assessment of recrudescence or reinfection after antimalarial drug treatment (review) Parasitology Today 14 1998 462-467
21. Staedke S. Kamya M. Dorsey G. Gasasira A. Ndeezi G. Charlebois E.D. Rosenthal P.J. A randomized trial of amodiaquine, sulfadoxine-pyrimethamine, and combination therapy for the treatment of uncomplicated falciparum malaria in Kampala, Uganda Lancet 358 2001 368-374
22. Trigg J.K. Mbwana O. Chambo O. Hills E. Watkins W. Curtis C.F. Resistance to pyrimethamine/ sulfadoxine in Plasmodium falciparum in 12 villages in north east Tanzania and a test of chlorproguanil/dapsone Acta Tropica 63 1997 185-189
23. von Seidlein L. Milligan P. Pinder M. Bojang K. Anyalebechi C. Gosling R. Coleman R. Ude J.L. Sadiq A. Duraisingh M. Warhurst D. Alloueche A. Targett G. McAdam K. Greenwood B. Walraven G. Olliaro P. Doherty T. Efficacy of artesunate plus pyrimethamine-sulphadoxine for uncomplicated malaria in Gambian children: a double-blind, randomized, controlled trial Lancet 355 2000 352-357
24. Watkins W.M. Percy M. Crampton J.M. Ward S. Koech D. Howells R.E. The changing response of Plasmodium falciparum to antimalarial drugs in East Africa Transactions of the Royal Society of Tropical Medicine and Hygiene 82 1988 21-26
25. Wernsdorfer W.H. Payne D. The dynamics of drug resistance in Plasmodium falciparum Pharmacology and Therapeutics 50 1991 95-121
26. White N.J. Assessment of the pharmacodynamic properties of antimalarial drugs in vivo Antimicrobial Agents and Chemotherapy 41 1997 1413-1422
27. White N.J. Delaying antimalarial drug resistance with combination chemotherapy Parassitologia 41 1999 301-308
28. White N.J. Olliaro P. Strategies for the prevention of antimalarial drug resistance: rationale for combination chemotherapy for malaria Parasitology Today 12 1996 399-401
29. White N.J. Olliaro P. Artemisinin and derivatives in the treatment of uncomplicated malaria Médecine Tropicale: Revue du Corps de Santé Colonial 58 1998 54-56
30. White N.J. Nosten F. Looareesuwan S. Watkins W.M. Marsh K. Snow R.W. Kokwaro G. Ouma J. Hien T.T. Molyneux M.E. Taylor T.E. Newbold C.L. Ruebush T.K. Danis M. Greenwood B.M. Anderson R.M. Olliaro P. Averting a malaria disaster Lancet 353 1999 1965-1967
31. WHO Chemotherapy of Malaria and Resistance to Antimalarials. Report of a WHO Scientific Working Group Technical Report Series, No. 529 1973 World Health OrganizationGeneva
32. WHO Severe and complicated malaria Transactions of the Royal Society of Tropical Medicine and Hygiene 84 supplement 2 1990 2nd edition
33. WHO Assessment of Therapeutic Efficacy ofAntimalarial Drugs for Uncomplicated Falciparum Malaria in Areas with Intense Transmission 1996 World Health Organzation Geneva WHO/MAL/96.1077
34. WHO Antimalarial Drug Combination Therapy. Report of a WHO Technical Consultation 2001 World Health OrganizationGeneva WHO/CDS/RBMI2001.35
35. Winstanley P. Chlorproguanil-dapsone (LAPDAP) for uncomplicated falciparum malaria Tropical Medicine and International Health 6 2001 952-954
36. Wolday D. Kibreab T. Bukenya D. Hodes R. Sensitivity of Plasmodium falciparum in vivo to chloroquine and pyrimethamine-sulfadoxine in Rwandan patients in a refugee camp in Zaire Transactions of the Royal Society of Tropical Medicine and Hygiene 89 1995 654-656